These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15274408)

  • 21. Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.
    Kawata N; Nagane Y; Hirakata H; Ichinose T; Okada Y; Yamaguchi K; Takahashi S
    Urology; 2007 Jun; 69(6):1049-53. PubMed ID: 17572184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel prognostic index in colorectal cancer defined by serum carcinoembryonic antigen and plasma tissue inhibitor of metalloproteinases-1.
    Nielsen HJ; Christensen IJ; Brünner N
    Scand J Gastroenterol; 2010; 45(2):200-7. PubMed ID: 20095885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High serum TIMP-1 is associated with adverse prognosis in endometrial carcinoma.
    Honkavuori M; Talvensaari-Mattila A; Puistola U; Turpeenniemi-Hujanen T; Santala M
    Anticancer Res; 2008; 28(5A):2715-9. PubMed ID: 19035300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gelatinases and their tissue inhibitors in ovarian tumors; TIMP-1 is a predictive as well as a prognostic factor.
    Rauvala M; Puistola U; Turpeenniemi-Hujanen T
    Gynecol Oncol; 2005 Dec; 99(3):656-63. PubMed ID: 16112717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lymph node micrometastases and expression of metastasis-related gene proteins in patients with colorectal cancer].
    Fan YZ; Li XP; Liu WF; Li GM
    Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):181-5. PubMed ID: 16635348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
    Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R
    Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High preoperative plasma fibrinogen levels are associated with distant metastases and impaired prognosis after curative resection in patients with colorectal cancer.
    Tang L; Liu K; Wang J; Wang C; Zhao P; Liu J
    J Surg Oncol; 2010 Oct; 102(5):428-32. PubMed ID: 20672316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers.
    Curran S; Dundas SR; Buxton J; Leeman MF; Ramsay R; Murray GI
    Clin Cancer Res; 2004 Dec; 10(24):8229-34. PubMed ID: 15623598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue MMP-2 and MMP-9 [corrected] are better prognostic factors than serum MMP-2/TIMP-2--complex or TIMP-1 [corrected] in stage [corrected] I-III lung carcinoma.
    Hoikkala S; Pääkkö P; Soini Y; Mäkitaro R; Kinnula V; Turpeenniemi-Hujanen T
    Cancer Lett; 2006 May; 236(1):125-32. PubMed ID: 15982804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tissue inhibitor of metalloproteinase-1 (TIMP-1) in colorectal cancer: correlation with clinico-morphological factors].
    Korotkova EA; Gershteĭn ES; Prorokov VV; Kushlinskiĭ NE
    Vopr Onkol; 2009; 55(2):171-6. PubMed ID: 19514370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
    Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
    Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphatic microvessel density is an independent prognostic factor in colorectal cancer.
    Matsumoto K; Nakayama Y; Inoue Y; Minagawa N; Katsuki T; Shibao K; Tsurudome Y; Hirata K; Nagata N; Itoh H
    Dis Colon Rectum; 2007 Mar; 50(3):308-14. PubMed ID: 17164964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical significance of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in peripheral blood of patients with gastric carcinoma].
    Yoshikawa T; Suzuki K; Kobayashi O; Sairenji M; Motohashi H; Yanoma S; Noguchi Y; Tsuburaya A
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1461-4. PubMed ID: 9703854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative plasma TIMP-1 is an independent prognostic indicator in patients with primary colorectal cancer: a prospective validation study.
    Birgisson H; Nielsen HJ; Christensen IJ; Glimelius B; Brünner N
    Eur J Cancer; 2010 Dec; 46(18):3323-31. PubMed ID: 20619633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galectin-3 expression is a potent prognostic marker in colorectal cancer.
    Endo K; Kohnoe S; Tsujita E; Watanabe A; Nakashima H; Baba H; Maehara Y
    Anticancer Res; 2005; 25(4):3117-21. PubMed ID: 16080575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of tissue inhibitor of metalloproteinase-1 in colorectal carcinoma and its clinical implications].
    Liu Y; Jiang B; Tong HS; Lai XR
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):699-700. PubMed ID: 16762889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer.
    Cho YB; Lee WY; Song SY; Shin HJ; Yun SH; Chun HK
    Hum Pathol; 2007 Nov; 38(11):1603-10. PubMed ID: 17669467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein.
    Ruokolainen H; Pääkkö P; Turpeenniemi-Hujanen T
    Clin Cancer Res; 2005 May; 11(9):3257-64. PubMed ID: 15867221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.